(Q44471766)

3 December 2017

title

Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era. (English)

1 reference

3 December 2017

Ziyad Ghazzal

1

1 reference

3 December 2017

Salman Ashfaq

2

1 reference

3 December 2017

Douglas C Morris

3

1 reference

3 December 2017

John S Douglas

4

1 reference

3 December 2017

John J Marshall

5

1 reference

3 December 2017

Spencer B King

6

1 reference

3 December 2017

William S Weintraub

7

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

3 December 2017

published in

American Heart Journal

1 reference

3 December 2017

volume

145

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

1006-1012

1 reference

Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Paucity of subtle myocardial injury after angioplasty delineated with MB CK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Changes in myoglobin, creatine kinase and creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Prognostic implication of creatine kinase elevation following elective coronary artery interventions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Creatine kinase release after successful percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following cita

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Minimal myocardial damage during coronary intervention is associated with impaired outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Beneficial impact of preconditioning during PTCA on creatine kinase release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Angiographic predictors of a rise in serum creatine kinase (distal embolization) after balloon angioplasty of saphenous vein coronary artery bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

Myonecrosis after revascularization procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900095-4

10.1016/S0002-8703(03)00095-4

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference